The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:14
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [31] Impact of radical radiotherapy in lung cancer an assessment of cardiac and pulmonary volume changes in patients with locally advanced non-small cell lung cancer following radical radiotherapy
    Ottewill, C.
    Vivekanandan, S.
    Cooke, R.
    Chu, K. Y.
    Higgins, G.
    Panakis, N.
    Stuart, R.
    Hawkins, M.
    LUNG CANCER, 2018, 115 : S72 - S72
  • [32] The Tumor Microenvironment in Non-Small-Cell Lung Cancer
    Graves, Edward E.
    Maity, Amit
    Le, Quynh-Thu
    SEMINARS IN RADIATION ONCOLOGY, 2010, 20 (03) : 156 - 163
  • [33] Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
    Nam Vu
    Onishi, Hiroshi
    Saito, Masahide
    Kuriyama, Kengo
    Komiyama, Takafumi
    Marino, Kan
    Araya, Masayuki
    Aoki, Shinichi
    Saito, Ryo
    Nonaka, Hotaka
    Funayama, Satoshi
    Watanabe, Hiroaki
    Sano, Naoki
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (05) : 740 - 746
  • [34] TUMOR VOLUME IS A PROGNOSTIC FACTOR IN NON-SMALL-CELL LUNG CANCER TREATED WITH CHEMORADIOTHERAPY
    Alexander, Brian M.
    Othus, Megan
    Caglar, Hale B.
    Allen, Aaron M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1381 - 1387
  • [35] Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer
    Etiz, D
    Marks, LB
    Zhou, SM
    Bentel, GC
    Clough, R
    Hernando, ML
    Lind, PA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (04): : 835 - 846
  • [36] Plasma Metabolomics in Non-small-cell Lung Cancer
    De Petris, L.
    Forshed, J.
    Antti, H.
    Branden, E.
    Koyi, H.
    Johnsson, A.
    Lewensohn, R.
    Lehtio, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S124 - S124
  • [37] Postoperative radiotherapy in non-small-cell lung cancer - Reply
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (03) : 136 - 137
  • [38] Metabolic imaging in non-small-cell lung cancer radiotherapy
    Geets, X.
    Sterpin, E.
    Wanet, M.
    Di Perri, D.
    Lee, J.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 402 - 405
  • [40] Radiotherapy and targeted therapies in non-small-cell lung cancer
    Girard, N.
    Mornex, F.
    BULLETIN DU CANCER, 2009, 96 (03) : 311 - 319